Lyobead

Based in China, Lyobead is a biotechnology company specializing in the development of biol, focusing on contract manufacturing of lyophilized beads essential for preserving biological materials across various applications. Founded in 2022 and headquartered in Suzhou, China, Lyobead is dedicated to contract manufacturing lyophilized beads. The company conducted its first deal on June 17, 2025. Lyobead specializes in contract manufacturing for lyophilized beads, critical products in the biotechnology sector.

Their lyobeads stabilize biological materials for applications including pharmaceuticals, diagnostics, and research. They serve a diverse clientele, including pharmaceutical companies, research institutions, and clinical laboratories, primarily in North America, Europe, and Asia, ensuring that their offerings meet stringent industry standards. The revenue structure of Lyobead is based on B2B transactions with pharmaceutical and research organizations requiring custom contract manufacturing services. Clients engage them for lyophilized beads tailored to specifications through long-term partnerships or project-based contracts, potentially involving tiered pricing based on order size or exclusivity agreements.

In June 2025, Lyobead raised an undisclosed amount of venture funding from undisclosed investors. The company plans to utilize this funding to develop new products and enhance its market presence. They aim to expand into additional regions, specifically targeting North America and Europe, by 2026.